Biomarkers Search

BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3320851)

61. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer.
Rose PG
Oncologist; 2005 Mar; 10(3):205-14. PubMed ID: 15793224
[TBL] [Abstract][Full Text] [Related]

62. [Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer].
Hernádi Z; Juhász B; Póka R; Mahunka I; Lampé L
Orv Hetil; 1987 Nov; 128(47):2457-61. PubMed ID: 3320851
[No Abstract] [Full Text] [Related]

63. [Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University].
Krommer K
Orv Hetil; 1992 May; 133(19):1151-8. PubMed ID: 1584596
[TBL] [Abstract][Full Text] [Related]

64. [Drug therapy of ovarian carcinoma].
Dittrich C
Wien Med Wochenschr; 1996; 146(1-2):23-34. PubMed ID: 8835492
[TBL] [Abstract][Full Text] [Related]

65. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Sevelda P
Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702
[TBL] [Abstract][Full Text] [Related]

66. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]

67.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]

68.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]

69.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]

[Previous] [New Search]